feed,title,long_url,short_url
ðŸ’°Barrons,BioMarin is Buying a Rare-Disease Biotech for Nearly $5 Billion. The Stock Is Jumping.,https://barrons.com/articles/biomarin-stock-jumps-amicus-therapeutics-deal-9a22d4a6?mod=RTA,
